QETYPRA
LIVE

Serial Number

79337835

Owner

IPSEN PHARMA S.A.S

Attorney

Ben Natter

Filing Date

Feb 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

QETYPRA Trademark

Serial Number: 79337835 • Registration: 7238318

QETYPRA is a trademark filed by IPSEN PHARMA S.A.S on February 16, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

IPSEN PHARMA S.A.S

65 quai Georges Gorse

Entity Type: 99

IPSEN PHARMA S.A.S. (154 trademarks)

65 QUAI GEORGES GORSE
BOULOGNE-BILLANCOURT 92100 , FR

Entity Type: 11

Trademark Details

Filing Date

February 16, 2022

Registration Date

December 12, 2023

Published for Opposition

September 26, 2023

Goods & Services

Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue disease, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospam, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Pharmaceutical preparations containing notably botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified components of the toxin haemagglutin complex for skin care and the treatment of neurological disorders

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 2, 2026 ADCH
INTERNATIONAL REGISTRATION RENEWED
Jul 16, 2024 RNWL
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 29, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 13, 2024 FICS
FINAL DISPOSITION PROCESSED
Mar 13, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 12, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 12, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 12, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Oct 31, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 3, 2023 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 26, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 26, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 13, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 13, 2023 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 6, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 6, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 6, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 22, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 19, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 19, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 19, 2023 TROA
REFUSAL PROCESSED BY IB
Feb 27, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 27, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 27, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 10, 2022 RFCR
NON-FINAL ACTION WRITTEN
Dec 9, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 1, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 12, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2022 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Apr 7, 2022 SDRC